当前位置: 首页 > 期刊 > 《河北医学》 > 2006年第2期
编号:10936307
原发性肝癌介入治疗结合三维适形放射治疗疗效观察
http://www.100md.com 《河北医学杂志》 2006年第2期
肝癌,,肝癌;,介入栓塞;,三维适形放射治疗,1一般资料,2结果,3讨论,参考文献:
     摘要:目的:评价肝动脉化疗栓塞(TACE)结合三维适形放射治疗(3D-CRT)对原发性肝癌(PHC)的疗效。方法:对10例不能手术切除的原发性肝癌患者,采用先TACE后3D-CRT相结合,观察疗效及生存率,10例中单发病灶6例,多结节病灶4例。TACE 1次者5 例,2~3次以上者5例。放射治疗剂量54~64GY。单次分割剂量3~5GY。结果:治疗后1年、两年的肿瘤局部有效率分别为90%、65%。 1~2年生存率分别为90 %、30% ,中位生存期15个月。结论:TACE结合3D-CRT是治疗PHC的有效无创治疗手段。

    关键词: 肝癌; 介入栓塞; 三维适形放射治疗

    The Efficiency of Primary Hepatic Carcinoma using Transcatheter Arterial Chemoembolization combine Three-dimension right Shape

    WANG Li-hua, LIU Quan, WANG Cui-ying, et al

    (The Second Hospital of Chifeng, Neimenggu Chifeng 024000, China)

    Abstract: Objective: To evaluate efficiency of primary hepatic carcinoma (PHC) using transcatheter arterial chemoembolization (TACE ) combine three-dimension right shape. Method: Ten patients with unresectable HCC adopt three-dimension right shape after the TACE first, observing curative effect and survival rate. 6 of 10 is one focus, 4 of 10 have more. 5 patients adopted TACE 1 time , patients adopted TACE more than 1 times is five. delivered dose of 53~60Gy . Result: One year after treating finally, the partly effective was 90.%.、65%.1~2 years survival rate respectively is 90%、30%.median life span is 15 months. Conclusion:To treat PHC with TACE combine three-dimension right shape is an effectively and no insult method. ......

您现在查看是摘要页,全文长 5357 字符